Steven Cohen Bionomics Limited Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bionomics Limited stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 316,000 shares of BNOX stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

316,000

Previous 316,000 -0.0%

Holding current value

$1.27 Million

Previous $243,000 42.8%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.89 - $1.38 $13,350 - $20,700	-15,000 Reduced 4.53%	316,000 $325,000
Q4 2023 Feb 14, 2024	SELL	$1.13 - $4.46 $373,607 - $1.47 Million	-330,626 Reduced 49.97%	331,000 $489,000
Q3 2023 Nov 14, 2023	BUY	$0.95 - $3.37 $508,844 - $1.81 Million	535,626 Added 425.1%	661,626 $1.79 Million
Q2 2023 Aug 14, 2023	SELL	$1.96 - $2.9 $3,920 - $5,800	-2,000 Reduced 1.56%	126,000 $277,000
Q4 2022 Feb 14, 2023	BUY	$4.65 - $9.67 $595,200 - $1.24 Million	128,000 New	128,000 $595,000

About BIONOMICS LIMITED

Ticker BNOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,518,620
Market Cap $30.3M
Description
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...

More about BNOX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account